Reversal of drug resistance in multidrug-resistant human lung cancer cells by retrovirus-mediated MDR1 antisense RNA

Chinese Science Bulletin

Volumn 41, Issue 23, 1996, Pages 1996-2000

  Gao, Zhenqiang ^a   Gao, Zhiping ^a  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

Author keywords

Lung cancer; MDR1 antisense RNA; Retrovirus; Reversal of drug resistance

Indexed keywords

EID: 0642276982     PISSN: 10016538     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (8)

1. Gottesman, M. M., How cancer cells evade chemotherapy, Cancer Res., 1993, 53. 747.
2. Tseng, B. Y., Brown, K. D., Antisense oligonucleotide technology in the development of cancer therapeutics. Cancer Gene Ther, 1994, 1: 65.
3. Gao, Z. Q., Gao, Z. P., Quantitative PCR analysis of MDR1 gene in human lung cancers, in Basic Medical Sciences (in Chinese) (ed. Ge, L. H.), Beijing: China Personnel Press, 1995, 574-578.
4. Ueda, K., Cardarell, C., Gottesman, M. et al , Expression of a full-length cDNA for the human MDR1 gene confers resistance to colchicine, doxorubicin, and vinblastine, PNAS USA, 1987, 84: 3004.
5. Gao, Z. Q., Gao, Z. P., Zhang, X. B., Growth inhibition of human lung cancer cells by p53-wt, Chin. J. Prevention and Control of Chronic Non-communicale Dis. (in Chinese), 1996, 2: 63.
6. Mosman, T., Rapid colorimetric assay for cell growth and survival, J. Immunol. Methods, 1983, 65: 55.
7. Gregory, P., Kalemkerian, M. D., Biology of lung cancer, Cur. Opin. Oncol., 1994, 4: 147
8. Douglas, J., Viral vector systems for gene therapy. Cancer Gene Ther., 1994, 1: 51.